Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
about
New Phase of Growth for Xenogeneic-Based Bioartificial OrgansRegulation of Clinical Xenotransplantation-Time for a Reappraisal.The Resurgence of Xenotransplantation.Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?Xenotransplantation: past, present, and future.PERVading strategies and infectious risk for clinical xenotransplantation
P2860
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
@en
type
label
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
@en
prefLabel
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.
@en
P2093
Carolyn Wilson
Takele Argaw
Winston Colon-Moran
P2860
P304
P356
10.1111/XEN.12230
P577
2016-03-29T00:00:00Z